98354457

Information

  • Trademark
  • 98354457
  • Serial Number
    98354457
  • Filing Date
    January 12, 2024
    a year ago
  • Transaction Date
    April 02, 2025
    15 days ago
  • Status Date
    April 01, 2025
    16 days ago
  • Published for Opposition Date
    April 01, 2025
    16 days ago
  • Location Date
    March 12, 2025
    a month ago
  • Status Code
    686
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    CHUO, EMILY
  • Attorney Docket Number
    NEUB 2401120
    Attorney Name
    Allison Strickland Ricketts
    Law Office Assigned Location Code
    L10
  • Owners
Mark Drawing Code
2
Case File Statements
  • DM0000: The mark consists of two same size arches with rounded end points. The front arch begins to the left of the back arch and covers a portion of the back arch. The front arch appears in a gradient from left to right from light blue to dark blue. The back arch appears in a gradient from left to right from purple to magenta.
  • GS0051: pharmaceutical preparations for the diagnosis, prevention and treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia
  • CC0000: The color(s) light blue, dark blue, purple, and magenta is/are claimed as a feature of the mark.
  • GS0441: Providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on-line information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders
  • GS0421: providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia and other endocrine diseases and disorders; Conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders; conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results
Case File Event Statements
  • 1/12/2024 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 5/5/2024 - 11 months ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 5/5/2024 - 11 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/22/2024 - 11 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/30/2024 - 10 months ago
    5 - PRIORITY ACTION WRITTEN Type: CPRA
  • 5/30/2024 - 10 months ago
    7 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN
  • 7/31/2024 - 8 months ago
    8 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 8/15/2024 - 8 months ago
    12 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN
  • 8/15/2024 - 8 months ago
    11 - PRIORITY ACTION E-MAILED Type: GPRA
  • 8/15/2024 - 8 months ago
    10 - PRIORITY ACTION WRITTEN Type: CPRA
  • 8/27/2024 - 7 months ago
    13 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 8/27/2024 - 7 months ago
    14 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 5/30/2024 - 10 months ago
    6 - PRIORITY ACTION E-MAILED Type: GPRA
  • 7/31/2024 - 8 months ago
    9 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 3/9/2025 - a month ago
    16 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 3/9/2025 - a month ago
    15 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 3/9/2025 - a month ago
    17 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 3/9/2025 - a month ago
    18 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 3/9/2025 - a month ago
    19 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/26/2025 - 22 days ago
    20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/1/2025 - 16 days ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/1/2025 - 16 days ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB